Life Sciences Insights | CF - Carnall Farrar

Life Sciences organizations must be nimble to address the demands of a new health care paradigm.

Discover the latest thinking from CF on the life sciences and healthcare industry, with a focus on operating in a world living with COVID.

All Life Sciences & Pharma COVID-19 Population Health Performance Improvement Finance & Capital

The impact of COVID-19 on cancer

Cardiovascular disease and COVID-19

Why the Oxford vaccine holds lessons for NHS leaders

The race for the COVID-19 vaccine: A story of innovation and collaboration

Preparing for delivering the vaccine

The international impact of NICE

Setting up NICE

Disruption and recovery of cancer from COVID-19

NHS England interim treatment changes during the COVID-19 pandemic

R&D investment in Life Sciences: Where are the gaps?

2020 Vision: What do we need to plan for now?

What will it mean to improve outcomes for lung cancer patients?

A Lost Decade – the data behind the report

COVID-19 response, exit, recovery, and the future

Health is Wealth

COVID-19, digital adoption, and primary care

Cancer post-COVID: impact, outcomes and next steps

State of Innovation

The Darzi Review Summary

NHS Long Term Plan Summary